Do you find our website to be helpful?
Yes   No

15 Years Ago

“Before the advent of sentinel node biopsy essentially all women with invasive cancer had to have a complete axillary lymph node dissection…. So in the course of less than 15 years, we have gone from 100% of women with invasive cancer having a complete dissection to around 10% – that is tremendous progress in lessening the morbidity of breast cancer surgical treatment.”  Dr. Peter Beitsch

You Might Also Enjoy...

Breast Cancer Prevention in Postmenopausal Women

A study presented at the annual meeting of the American Society of Clinical Oncology and published online by the NEJMindicates Exemestane, which is now used to prevent recurrences of breast cancer, can also reduce the risk of it occurring.